A 4.2 kDa synthetic peptide as a potential probe to evaluate the antibacterial activity of coumarin drugs

Journal of Peptide Science

Volumn 10, Issue 9, 2004, Pages 566-577

  Scatigno, Andreza C ^a,b   Garrido, Saulo S ^a   Marchetto, Reinaldo ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSIDADE DO OESTE DE SANTA CATARINA   (Brazil)

Author keywords

Affinity chromatography; Coumarins; DNA gyrase; Fluorescence; Peptide synthesis; Peptides; Solid phase

Indexed keywords

ADENOSINE TRIPHOSPHATE; ARGININE; COUMARIN DERIVATIVE; DNA FRAGMENT; DNA TOPOISOMERASE (ATP HYDROLYSING) B; DNA TOPOISOMERASE INHIBITOR; ESCHERICHIA COLI PROTEIN; LEUCINE; MUTANT PROTEIN; NOVOBIOCIN; PLASMID DNA; SYNTHETIC PEPTIDE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATE; BINDING AFFINITY; CONTROLLED STUDY; DNA DRUG COMPLEX; DRUG CLASSIFICATION; DRUG DESIGN; DRUG DNA BINDING; DRUG PROTEIN BINDING; DRUG RESISTANCE; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; ESCHERICHIA COLI; MOLECULAR MIMICRY; MOLECULAR PROBE; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; PROTEIN SYNTHESIS; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

ADENOSINE TRIPHOSPHATE; ANTI-BACTERIAL AGENTS; BINDING, COMPETITIVE; COUMARINS; DNA; DNA GYRASE; DRUG EVALUATION, PRECLINICAL; ENZYME INHIBITORS; MOLECULAR PROBES; NOVOBIOCIN; PEPTIDES;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 4544345022     PISSN: 10752617     EISSN: None     Source Type: Journal    
DOI: 10.1002/psc.565     Document Type: Article

References (36)

1. Reece RJ, Maxwell A. DNA gyrase: structure and function. Crit. Rev. Biochem. Mol. Biol 1991; 26: 335-375.
2. Wigley DB. Structure and mechanism of DNA gyrase. In Nucleic Acids and Molecular Biology Eckstein F, Lilley DMJ (eds). Springer-Verlag: Berlin, Heidelberg 1995; 9: 165-176.
3. Sugino A, Higgins NP, Brown PO, Peebles CL, Cozzarelli NR. Energy coupling in DNA gyrase and the mechanism of action of novobiocin. Proc. Natl Acad. Sci. USA 1978; 75: 4838-4842.
4. Reece RJ, Maxwell A. Tryptic fragments of the Escherichia coli DNA gyrase A protein. J. Biol. Chem. 1989; 264: 19 648-19 653.
5. Reece RJ, Maxwell A. Probing the limits of the DNA breakage-reunion domain of the Escherichia coli DNA gyrase A protein. J. Biol. Chem. 1991; 266: 3540-3546.
6. Ali JA, Jackson AP, Howells AJ, Maxwell A. The 43-kilodalton N-terminal fragment of DNA gyrase B protein hydrolyses ATP and binds coumarin drugs. Biochemistry 1993; 32: 2717-2724.
7. Brown PO, Peebles CL, Cozzarelli NR. A topoisomerase from Escherichia coli related to DNA gyrase. Proc. Natl Acad. Sci. USA 1979; 76: 6110-6114.
8. Wigley DB, Davies GJ, Dodson EJ, Maxwell A, Dodson G. Crystal structure of an N-terminal fragment of the DNA gyrase B protein. Nature 1991; 351: 624-629.
9. Maxwell A. DNA gyrase as a drug target. Trends Microbiol. 1997; 5: 102-109.
10. Shen LL, Kohlbrenner WE, Weigl D, Baranowski J. Mechanism of quinolone inhibition of DNA gyrase: appearance of unique norfloxacin binding sites in enzyme-DNA complexes. J. Biol. Chem. 1989; 264: 2973-2978.
11. Gormley NA, Orphanides G, Meyer A, Cullis PM, Maxwell A. The interaction of coumarin antibiotics with fragments of the DNA gyrase B protein. Biochemistry 1996; 35: 5083-5092.
12. Sissi C, Perdona E, Domenici E, Feriani A, Howells AJ, Maxwell A, Palumbo M. Ciprofloxacin affects conformational equilibria of DNA gyrase A in the presence of magnesium ions. J. Mol. Biol. 2001; 311: 195-203.
13. Tsai FTF, Singh OMP, Skarzynsky T, Wonacott AJ, Weston S, Tucker A, Pauptit RA, Breeze AL, Poyser JP, O'Brien R, Ladbury JE, Wiglex DB. The high-resolution crystal structure of a 24-kDa gyrase B fragment from E. coli complexed with one of the most potent coumarin inhibitors, clorobiocin. Proteins 1997; 28: 41-52.
14. Lewis RJ, Singh OMP, Smith CV, Skarzynski T, Maxwell A, Wonacott AJ, Wigley DB. The nature of inhibition of DNA gyrase by the coumarins and the cyclothialidines revealed by x-ray crystallography. EMBO J. 1996; 15: 1412-1420.
15. Funatsuki K, Tanaka R, Inagaki S, Konno H, Katoh K, Nakamura H. acrB Mutation located at carboxy-terminal region of gyrase B subunit reduces DNA binding of DNA gyrase. J. Biol. Chem. 1997; 272: 13 302-13 308.
16. Maxwell A. DNA gyrase as a drug target. Biochem. Soc. Trans. 1999; 27: 48-53.
17. Marchetto R, Nicolas E, Castillo N, Bacardit J, Navia M, Vila J, Giralt E. Two short peptides including segments of subunit A of Escherichia coli DNA/gyrase as potential probes to evaluate the antibacterial activity of quinolones. J. Peptide Sci. 2001; 7: 27-40.
18. Lacowicz JR. Principles of Fluorescence Spectroscopy. Plenum Press: New York, USA, 1987.
19. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual (2nd edn). Cold Spring Harbor Laboratory Press: Cold Spring Harbor, New York, USA, 1989.
20. Fields GB, Noble RL. Solid-phase peptide synthesis utilizing 9-fluorenyl-methoxycarbonyl amino acids. Int. J. Peptide Protein Res. 1990; 35: 161-214.
21. Borissevitch IE. More about the inner filter effect: corrections of Stern-Volmer fluorescence quenching constants are necessary at very low optical absorption of the quencher. J. Luminescence 1999; 81: 219-224.
22. Maxwell A. The interaction between coumarin drugs and DNA gyrase. Mol. Microbiol. 1993; 9: 681-686.
23. Contreras A, Maxwell A. gyrB mutations which confer coumarin resistance also affect DNA supercoiling and ATP hydrolysis by Escherichia coli DNA gyrase. Mol. Microbiol. 1992; 6: 1617-1624.
24. Berger JM, Gamblin SJ, Harrison SC, Wang JC. Structure and mechanism of DNA topoisomerase II. Nature 1996; 379: 225-232.
25. 1. Proc. Natl Acad. Sci USA 1991; 88: 8860-8864.
26. Holdgate GA, Tunnicliffe A, Ward WHJ, Weston SA, Rosembrock G, Barth PT, Taylor LWF, Pauptit RA, Timms D. The entropy penalty of ordered water accounts for weaker binding of the antibiotic novobiocin to a resistant mutant of DNA gyrase: A thermodynamic and crystallographic study. Biochemistry 1997; 36: 9663-9673.
27. Sekiguchi J, Stivers JT, Mildvan AS, Shuman S. Mechanism of inhibition of vaccinia DNA topoisomerase by novobiocin and coumermycin. J. Biol. Chem. 1996; 271: 2313-2322.
28. Gellert M, O'Dea MH, Itoh T, Tomizawa J. Novobiocin and coumermycin inhibit DNA supercoiling catalysed by DNA gyrase. Proc. Natl Acad. Sci. USA 1976; 73: 4474-4478.
29. Mizuuchi K, O'Dea MH, Gellert M. DNA gyrase: subunit structure and ATPase activity of the purified enzyme. Proc. Natl Acad. Sci. USA 1978; 75: 5960-5963.
30. Maxwell A, Gellert M. The DNA dependence of the ATPase activity of DNA gyrase. J. Biol. Chem. 1984; 259: 14 472-14 480.
31. Noble CG, Maxwell A. The role of GyrB in the DNA cleavage-religation reaction of DNA gyrase: a proposed two metal-ion mechanism. J. Mol. Biol. 2002; 318: 361-371.
32. Gilbert EJ, Maxwell A. The 24kDa N-terminal subdomain of the DNA gyrase B protein binds coumarin drugs. Mol. Microbiol. 1994; 12: 365-373.
33. Tamura JK, Bates AD, Gellert M. Slow interaction of 5′-adenylyl-β,γ-imido-diphosphate with Escherichia coli DNA gyrase. J. Biol. Chem. 1992; 267: 9214-9222.
34. Sugino A, Cozzarelli NR. The intrinsic ATPase of DNA gyrase. J. Biol. Chem. 1980; 255: 6299-6306.
35. Morais Cabral JH, Jackson AP, Smith CV, Shikotra N, Maxwell A, Liddington RC. Crystal structure of the breakage-reunion domain of DNA gyrase. Nature 1997; 388: 903-906.
36. Kampranis SC, Gormley NA, Tranter R, Orphanides G, Maxwell A. Probing the binding of coumarins and cyclothialidines to DNA gyrase. Biochemistry 1999; 38: 1967-1976.